Published in Neurology on March 01, 1997
The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain (2008) 2.74
Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain (2012) 1.94
Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochem (2008) 1.29
Animal models of peripheral neuropathies. Neurotherapeutics (2012) 1.09
Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy. J Neurol Neurosurg Psychiatry (1998) 1.07
Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy. J Pain (2013) 1.06
Fine-grained nociceptive maps in primary somatosensory cortex. J Neurosci (2012) 1.04
Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts. BMC Neurol (2007) 1.00
Macrophage-mediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques. Am J Pathol (2011) 0.97
Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes. Neurobiol Dis (2011) 0.93
A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J Neurol (2005) 0.87
Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy. J Pain (2013) 0.86
Dietary selenium protects against selected signs of aging and methylmercury exposure. Neurotoxicology (2010) 0.84
SIV-induced impairment of neurovascular repair: a potential role for VEGF. J Neurovirol (2012) 0.83
Whole-body mapping of spatial acuity for pain and touch. Ann Neurol (2014) 0.82
Persistent Peripheral Nervous System Damage in Simian Immunodeficiency Virus-Infected Macaques Receiving Antiretroviral Therapy. J Neuropathol Exp Neurol (2015) 0.80
No adrenergic sensitization of afferent neurons in painful sensory polyneuropathy. J Neurol (2005) 0.80
The armadillo as a model for peripheral neuropathy in leprosy. ILAR J (2014) 0.79
Treatment of painful sensory neuropathy with tiagabine: a pilot study. Clin Auton Res (2001) 0.79
Loss of corneal sensory nerve fibers in SIV-infected macaques: an alternate approach to investigate HIV-induced PNS damage. Am J Pathol (2014) 0.79
Comparison of a simple method for quantitation of intraepidermal nerve fibres with a standard image analysis method using hypothenar skin. J Neurol (2006) 0.78
Foot pad skin biopsy in mouse models of hereditary neuropathy. Glia (2010) 0.78
The impact of low-dose insulin on peripheral nerve insulin receptor signaling in streptozotocin-induced diabetic rats. PLoS One (2013) 0.76
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations. J Pain (2017) 0.75
Tracking Epidermal Nerve Fiber Changes in Asian Macaques: Tools and Techniques for Quantitative Assessment. Toxicol Pathol (2016) 0.75
Neuropathy, retinopathy, and glucose-lowering treatments. Diabetes Care (2010) 0.75
HIV neuropathy: an in vivo confocal microscopic study. J Neurovirol (2012) 0.75
Painful neuropathy with skin denervation after prolonged use of linezolid. BMJ Case Rep (2009) 0.75
Degree of skin denervation and its correlation to objective thermal sensory test in leprosy patients. PLoS Negl Trop Dis (2012) 0.75
Clinical Characteristics, Electrophysiology, and Skin Biopsy of 38 Peripheral Neuropathy Cases with Small Fiber Involvement of Various Etiologies. Chin Med J (Engl) (2017) 0.75
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol (1990) 8.54
Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology (2007) 8.08
Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2011) 7.09
Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology (2011) 4.63
Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol (1995) 3.78
The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60
HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology (2001) 3.55
Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.23
HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 3.17
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology (2007) 3.14
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A (1998) 2.89
Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet (1991) 2.87
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.76
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol (1990) 2.66
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology (1999) 2.52
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47
Clinical-neuropathologic correlation in HIV-associated dementia. Neurology (1993) 2.47
Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci (1998) 2.43
Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell (1993) 2.40
Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci U S A (1987) 2.36
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain (1995) 2.29
Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol (1993) 2.23
Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol (1996) 2.22
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology (1977) 2.19
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology (2004) 2.18
Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS) Neurology (1990) 2.17
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology (2002) 2.17
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology (1997) 2.15
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol (1988) 2.12
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09
HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology (2006) 2.06
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol (1998) 2.05
Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol (1987) 2.05
Control of axonal caliber by neurofilament transport. J Cell Biol (1984) 2.03
Slow axonal transport of neurofilament proteins: impairment of beta,beta'-iminodipropionitrile administration. Science (1978) 2.00
Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J Neurosci (2006) 1.97
Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95
Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology (1995) 1.95
Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology (1988) 1.94
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol (1990) 1.92
Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology (1994) 1.88
Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci (1995) 1.88
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol (1989) 1.79
Relapse in Guillain-Barré syndrome after treatment with human immune globulin. Neurology (1993) 1.77
Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science (1996) 1.76
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol (1993) 1.73
Electron microscopic autoradiographic studies of gliogenesis in rat optic nerve. I. Cell proliferation. J Comp Neurol (1976) 1.71
Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics (1997) 1.70
Biomarkers of HIV-1 CNS infection and injury. Neurology (2007) 1.69
Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology (1993) 1.68
Dominant GDAP1 mutations cause predominantly mild CMT phenotypes. Neurology (2011) 1.67
Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology (2004) 1.66
Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J Neurosci (2001) 1.66
Schwann cell phenotype is regulated by axon modality and central-peripheral location, and persists in vitro. Exp Neurol (2013) 1.62
Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology (2007) 1.62
Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study. Percept Mot Skills (1991) 1.62
Electron microscopic autoradiographic studies of gliogenesis in rat optic nerve. II. Time of origin. J Comp Neurol (1976) 1.61
Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol (1988) 1.60
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol (2012) 1.60
Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology (1993) 1.59